This page shows Greater Cannabis (GCAN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Greater Cannabis passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Greater Cannabis generates $0.18 in operating cash flow (-$60K OCF vs -$332K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Greater Cannabis reported -$332K in net income in fiscal year 2025. This represents a decrease of 85.2% from the prior year.
Cash & Balance Sheet
Greater Cannabis held $815 in cash against $0 in long-term debt as of fiscal year 2025.
Greater Cannabis had 944,935 shares outstanding in fiscal year 2025. This represents an increase of 76.1% from the prior year.
Margins & Returns
Capital Allocation
GCAN Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -$37K+22.5% | -$48K-10.8% | -$44K | N/A | -$40K-3.0% | -$39K-0.8% | -$39K | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$36K+90.8% | -$391K-61.2% | -$242K | N/A | -$46K-2.8% | -$45K-0.7% | -$45K | N/A |
| EPS (Diluted) | $-0.04 | $0.00 | $0.00 | N/A | $-0.09 | $0.00 | $0.00 | N/A |
GCAN Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $21K-20.1% | $27K-42.2% | $46K-20.0% | $58K-9.6% | $64K-23.2% | $83K-37.6% | $133K-22.5% | $172K |
| Current Assets | $21K-20.1% | $27K-42.2% | $46K-19.4% | $57K-7.9% | $62K-22.5% | $80K-37.9% | $129K-22.5% | $167K |
| Cash & Equivalents | $21K-20.1% | $27K-42.2% | $46K-19.4% | $57K-7.9% | $62K-22.5% | $80K-37.9% | $129K-22.5% | $167K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $1.1M+2.8% | $1.1M+8.9% | $1.0M+12.4% | $898K+4.3% | $861K+3.2% | $834K-0.6% | $839K+0.7% | $834K |
| Current Liabilities | $1.1M+2.8% | $1.1M+8.9% | $1.0M+12.4% | $898K+4.3% | $861K+3.2% | $834K-0.6% | $839K+0.7% | $834K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$1.1M-3.4% | -$1.1M-11.4% | -$963K-14.6% | -$840K-5.4% | -$797K-6.1% | -$751K-6.4% | -$706K-6.7% | -$661K |
| Retained Earnings | -$5.3M-0.7% | -$5.3M-8.0% | -$4.9M-5.2% | -$4.7M-0.9% | -$4.6M-1.0% | -$4.6M-1.0% | -$4.5M-1.0% | -$4.5M |
GCAN Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$5K+72.5% | -$20K-74.8% | -$11K-127.0% | -$5K+72.8% | -$18K+63.2% | -$49K-30.6% | -$38K-14.9% | -$33K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
GCAN Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -169.0%+1294.2pp | -1463.2%-938.6pp | -524.6% | N/A | -72.2%-18.2pp | -54.0%-20.5pp | -33.4% | N/A |
| Current Ratio | 0.020.0 | 0.02-0.0 | 0.05-0.0 | 0.060.0 | 0.07-0.0 | 0.10-0.1 | 0.15-0.0 | 0.20 |
| Debt-to-Equity | -1.020.0 | -1.02+0.0 | -1.05+0.0 | -1.07+0.0 | -1.08+0.0 | -1.11+0.1 | -1.19+0.1 | -1.26 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$742K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.00), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Greater Cannabis profitable?
No, Greater Cannabis (GCAN) reported a net income of -$332K in fiscal year 2025.
What is Greater Cannabis's operating cash flow?
Greater Cannabis (GCAN) generated -$60K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Greater Cannabis's total assets?
Greater Cannabis (GCAN) had $815 in total assets as of fiscal year 2025, including both current and long-term assets.
What is Greater Cannabis's current ratio?
Greater Cannabis (GCAN) had a current ratio of 0.00 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Greater Cannabis's debt-to-equity ratio?
Greater Cannabis (GCAN) had a debt-to-equity ratio of -1.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Greater Cannabis's return on assets (ROA)?
Greater Cannabis (GCAN) had a return on assets of -40688.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Greater Cannabis's cash runway?
Based on fiscal year 2025 data, Greater Cannabis (GCAN) had $815 in cash against an annual operating cash burn of $60K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Greater Cannabis's debt-to-equity ratio negative or unusual?
Greater Cannabis (GCAN) has negative shareholder equity of -$742K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Greater Cannabis's Piotroski F-Score?
Greater Cannabis (GCAN) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Greater Cannabis's earnings high quality?
Greater Cannabis (GCAN) has an earnings quality ratio of 0.18x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.